China Cord Blood Corporation (CO)
(Delayed Data from NYSE)
$6.78 USD
+0.10 (1.50%)
Updated May 3, 2019 04:13 PM ET
After-Market: $6.75 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
China Cord Blood Corporation [CO]
Reports for Purchase
Showing records 1 - 20 ( 87 total )
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
Downgrading to Neutral Pending Going Private Decision
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
FY3Q15 Recap - Strong Quarter, Some Noise in 2016
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
FY2Q15 Recap - Growth Slowing, but Cash Flow Still Robust
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
1Q15 Recap - Revs and Expenses Light, but Not Cash Flow
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: China Cord Blood Corporation
Industry: Medical - Outpatient and Home Healthcare
4Q14 Recap - Largely as Expected; EPS Breakout Coming in FY16
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S